Posts

STAT+: Peter Marks on creating Operation Warp Speed, bu...

Peter Marks wants drug developers to ask more stupid questions. It’s part of the...

STAT+: Life sciences deals on track to hit lowest point...

It’s no secret that biotech industry funding has fallen from its Covid highs. Bu...

STAT+: Key takeaways from AdvaMed, the world’s largest ...

As AdvaMed concludes, here are the key takeaways from the world’s largest medica...

STAT+: CRO claims there was no misconduct in Lyme vacci...

A company that Pfizer blamed for problems with a clinical trial testing a Lyme v...

STAT+: Humana CEO Bruce Broussard to step down next year

Bruce Broussard will leave Humana next year. Jim Rechtin, CEO of the bankrupt En...

STAT+: Medicare may plan to negotiate drug prices, but ...

A handful of states are moving aggressively to slash drug costs for their reside...

STAT+: European regulators consider appeal over Amylyx ...

This week, European regulators are considering an appeal from Amylyx Pharmaceuti...

STAT+: In major test for eGenesis, gene-edited pig kidn...

In a major test for biotechnology company eGenesis, gene-edited pig kidneys kept...

With Ozempic, Wall Street moves on from a whole other c...

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Novo halts Ozempic kidney failure ...

Novo Nordisk plans to stop a trial of Ozempic to treat kidney failure after an i...

Major biomedical research funder Wellcome Trust names R...

The Wellcome Trust — the world’s second largest private funder of biomedical res...

Chronic kidney disease raises risk of sudden cardiac ar...

Chronic kidney disease was the strongest risk factor for sudden cardiac arrest a...

An electrical switch to control chemical reactions

New pharmaceuticals, cleaner fuels, biodegradable plastics: in order to meet soc...

Gray whales experience major population swings as a res...

NEWPORT, Ore. – Dynamic and changing Arctic Ocean conditions likely caused three...

Engineered bacteria paint targets on tumors for cancer-...

New York, NY—October 12, 2023—For several years, researchers have been successfu...

Researchers construct first “multiome” atlas of cell de...

A team of researchers from the Icahn School of Medicine at Mount Sinai and Yale ...